Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.

Xiao A, Zanwar S, Lin Y, Kapoor P, Abdallah N, Buadi FK, Binder M, Dispenzieri A, Dingli D, Gertz MA, Gonsalves W, Hayman SR, Kourelis T, Leung N, Muchtar E, Siddiqui M, Tan M, Warsame R, Rajkumar SV, Kumar S

Open source

DOI
10.1182/bloodadvances.2026020668
Published
2026 Sep 8
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026020668,
  title = {Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.},
  author = {Xiao A and Zanwar S and Lin Y and Kapoor P and Abdallah N and Buadi FK and Binder M and Dispenzieri A and Dingli D and Gertz MA and Gonsalves W and Hayman SR and Kourelis T and Leung N and Muchtar E and Siddiqui M and Tan M and Warsame R and Rajkumar SV and Kumar S},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026020668},
  url = {https://doi.org/10.1182/bloodadvances.2026020668}
}

RIS

TY  - JOUR
TI  - Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.
AU  - Xiao A
AU  - Zanwar S
AU  - Lin Y
AU  - Kapoor P
AU  - Abdallah N
AU  - Buadi FK
AU  - Binder M
AU  - Dispenzieri A
AU  - Dingli D
AU  - Gertz MA
AU  - Gonsalves W
AU  - Hayman SR
AU  - Kourelis T
AU  - Leung N
AU  - Muchtar E
AU  - Siddiqui M
AU  - Tan M
AU  - Warsame R
AU  - Rajkumar SV
AU  - Kumar S
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026020668
UR  - https://doi.org/10.1182/bloodadvances.2026020668
ER  - 

APA

A, X., S, Z., Y, L., P, K., N, A., FK, B., M, B., A, D., D, D., MA, G., W, G., SR, H., T, K., N, L., E, M., M, S., M, T., R, W., SV, R., & S, K. (2026). Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020668

Source records